These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17017516)

  • 1. A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease.
    Giorgi FS; Bandettini di Poggio A; Battaglia G; Pellegrini A; Murri L; Ruggieri S; Paparelli A; Fornai F
    J Neural Transm Suppl; 2006; (70):105-9. PubMed ID: 17017516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
    Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
    Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
    Fornai F; Lazzeri G; Bandettini Di Poggio A; Soldani P; De Blasi A; Nicoletti F; Ruggieri S; Paparelli A
    Ann N Y Acad Sci; 2006 Aug; 1074():84-9. PubMed ID: 17105905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.
    Fornai F; Schlüter OM; Lenzi P; Gesi M; Ruffoli R; Ferrucci M; Lazzeri G; Busceti CL; Pontarelli F; Battaglia G; Pellegrini A; Nicoletti F; Ruggieri S; Paparelli A; Südhof TC
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3413-8. PubMed ID: 15716361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.
    Kowall NW; Hantraye P; Brouillet E; Beal MF; McKee AC; Ferrante RJ
    Neuroreport; 2000 Jan; 11(1):211-3. PubMed ID: 10683860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and α-Synuclein, as Reported in ALS-PDC.
    Kisby GE; Eriksen JL; Chlebowski AC; Spencer PS
    J Neuropathol Exp Neurol; 2021 Feb; 80(3):286-288. PubMed ID: 33550390
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cellular model to monitor proteasome dysfunction by alpha-synuclein.
    Nonaka T; Hasegawa M
    Biochemistry; 2009 Aug; 48(33):8014-22. PubMed ID: 19630439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease.
    Meredith GE; Totterdell S; Petroske E; Santa Cruz K; Callison RC; Lau YS
    Brain Res; 2002 Nov; 956(1):156-65. PubMed ID: 12426058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.
    McNaught KS; Perl DP; Brownell AL; Olanow CW
    Ann Neurol; 2004 Jul; 56(1):149-62. PubMed ID: 15236415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
    Decressac M; Mattsson B; Björklund A
    Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking microtubules to Parkinson's disease: the case of parkin.
    Cappelletti G; Casagrande F; Calogero A; De Gregorio C; Pezzoli G; Cartelli D
    Biochem Soc Trans; 2015 Apr; 43(2):292-6. PubMed ID: 25849932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
    Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
    J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
    Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
    Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.